None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 19 years or older 2. Patients who are likely to undergo standard central laboratory coagulation testing (SCLT) or point-of-care viscoelastic testing (POCT) during surgery 3. Patients who provide written informed consent to participate in this study
Exclusion criteria
Exclusion criteria: 1. Pregnant women (because coagulation characteristics differ from those of the general population) 2. Patients who do not provide informed consent to participate in this study 3. Patients whom the investigators consider unsuitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic turnaround time of point-of-care viscoelastic testing (POCT) and standard central laboratory testing (SCLT), defined as the time from blood sample collection to availability of test results. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the diagnostic results between point-of-care viscoelastic testing (POCT) and standard central laboratory testing (SCLT);Comparison of the utilization rates of POCT and SCLT for the diagnosis of intraoperative coagulopathy;Comparison of the proportion of patients diagnosed with coagulopathy using POCT and SCLT;Agreement between POCT and SCLT in the diagnosis of intraoperative coagulopathy;Comparison of the time to treatment initiation, defined as the interval from prescription (ordering) of blood products or coagulation factor concentrates after review of the test results to the start of transfusion or administration;Comparison of the time to treatment completion, defined as the interval until completion of blood product transfusion;Comparison of blood product utilization according to the diagnostic results | — |
Countries
Korea, Republic of
Contacts
Konkuk University Medical Center